Back Back
ProCE Banner Activity

CME

IBD Management in Women of Childbearing Age: A Holistic Approach to Family Planning

In this interactive video, gain expert insights on helping women manage their IBD during their childbearing years, including addressing concerns about fertility, drug safety, and managing flares.

Physicians: maximum of 1.00 AMA PRA Category 1 CreditTM

Released: March 25, 2020

Expiration: March 24, 2021

No longer available for credit.
Begin Activity

Share

Faculty

Marla Dubinsky

Marla Dubinsky, MD

Professor of Pediatrics and Medicine
Chief, Division of Pediatric Gastroenterology and Nutrition
Co-Director, Susan and Leonard Feinstein IBD Clinical Center
Mount Sinai Kravis Children’s Hospital
Ichan School of Medicine, Mount Sinai New York
New York, New York

Uma Mahadevan

Uma Mahadevan, MD

Professor of Medicine, Division of Gastroenterology
Director, Center for Colitis and Crohn’s Disease
University of California San Francisco Medical School
San Francisco, California

Provided by

Provided by the American Gastroenterology Association.
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.

Target Audience

This program is intended for gastroenterologists, primary care clinicians, OB/GYN healthcare providers, and other clinicians who care for women of childbearing age with IBD who hope to become pregnant and/or are considering planning a family.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Summarize the evidence for successful pregnancy in women with IBD that can be conveyed to patients who desire to become pregnant
  • Outline the key tenets of caring for women with IBD who wish to become pregnant, including preconception counseling and the importance of a multidisciplinary team
  • Detail preconception IBD medical management recommended by the AGA regarding conventional and biologic therapies

Faculty Disclosure

Primary Author

Marla Dubinsky, MD

Professor of Pediatrics and Medicine
Chief, Division of Pediatric Gastroenterology and Nutrition
Co-Director, Susan and Leonard Feinstein IBD Clinical Center
Mount Sinai Kravis Children’s Hospital
Ichan School of Medicine, Mount Sinai New York
New York, New York

Marla Dubinsky, MD, has disclosed that she has received consulting fees from AbbVie, Arena, Bristol-Myers Squibb, Celgene, Genentech, Janssen, Lilly, Pfizer, Prometheus, and Takeda; has received funds for research support from AbbVie, Janssen, Pfizer, and Prometheus; has received royalties from Mi Test Health; and has ownership interest in Trellus Health.

Uma Mahadevan, MD

Professor of Medicine, Division of Gastroenterology
Director, Center for Colitis and Crohn’s Disease
University of California San Francisco Medical School
San Francisco, California

Uma Mahadevan, MD, had disclosed that she has received consulting fees from AbbVie, Allergan, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Takeda and funds for research support from Celgene and Pfizer.

Staff Disclosure

Staff

Lillian McVey,

Editorial Contributor

Lillian McVey has no relevant conflicts of interest to report.

Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.

Anne Roc, PhD

Director, Scientific Services

Anne Roc, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, has no relevant conflicts of interest to report.

Instructions for Credit

Accreditation Statement

American Gastroenterological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

American Gastroenterological Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 25, 2020, through March 24, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve the competence of learners to apply evidence-based medicine and expert commentary to develop preconception strategies that can help to ensure safe and effective IBD control before and during pregnancy.